Product Description - MedComp 46.7% DuraLock-C Manual Del Usuario

46.7% DuraLock-C™

PRODUCT DESCRIPTION:

DuraLock-C™ is supplied as a clear, plastic, prefilled
syringe, packaged in a pouch. Each DuraLock-C™ prefilled
syringe contains a sterile, clear and colorless solution
containing sodium citrate; pH is adjusted with citric acid.
INDICATIONS AND CLINICAL USE:
DuraLock-C™ is indicated for use in maintaining patency
of Hemodialysis Catheters.
ACTION:
Trisodium Citrate causes anticoagulation by chelating
ionized Calcium into a soluble complex. Calcium is
an integral ion involved in the clotting cascade. Local
removal by Citrate prevents the activation of clotting
cofactors, factor X and prothrombin and the ultimate
formation of fibrin. Systemic anticoagulation does not
occur.
INTENDED USE:
Short-Term, between 24hours-72hours, catheter lock
solution.
WARNING:
If catheter is not sufficiently locked, clots can form and
thrombosis may occur.
CONTRAINDICATIONS:
Patients with known allergies or hypersensitivity to
constituents.
STORAGE:
Duralock-C™ should be stored between 15-30°C and away
from exposure to direct sunlight and moisture.
-1-